300 related articles for article (PubMed ID: 33049522)
1. Transitional dynamics of cancer stem cells in invasion and metastasis.
Richard V; Kumar TRS; Pillai RM
Transl Oncol; 2021 Jan; 14(1):100909. PubMed ID: 33049522
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of Minimal Residual Disease in Neuroblastoma Patients.
Uemura S; Ishida T; Thwin KKM; Yamamoto N; Tamura A; Kishimoto K; Hasegawa D; Kosaka Y; Nino N; Lin KS; Takafuji S; Mori T; Iijima K; Nishimura N
Front Oncol; 2019; 9():455. PubMed ID: 31214500
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells, tumor dormancy, and metastasis.
Patel P; Chen EI
Front Endocrinol (Lausanne); 2012; 3():125. PubMed ID: 23109929
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease in advanced or metastatic solid cancers: The G0-G1 state and immunotherapy are key to unwinding cancer complexity.
Nicolini A; Rossi G; Ferrari P; Carpi A
Semin Cancer Biol; 2022 Feb; 79():68-82. PubMed ID: 32201368
[TBL] [Abstract][Full Text] [Related]
6. A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth.
Molina-Peña R; Tudon-Martinez JC; Aquines-Gutiérrez O
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932755
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology underlying the robustness of cancer stem cells.
Yoshida GJ; Saya H
Regen Ther; 2021 Jun; 17():38-50. PubMed ID: 33869685
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics.
Poli V; Fagnocchi L; Zippo A
Stem Cells Int; 2018; 2018():4598195. PubMed ID: 29853913
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic interconversion of B16 melanoma clonal cell populations: relationship between metastasis and tumor growth rate.
Stackpole CW; Fornabaio DM; Alterman AL
Int J Cancer; 1985 May; 35(5):667-74. PubMed ID: 3997286
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance.
Garg M
Cancer Metastasis Rev; 2022 Mar; 41(1):131-145. PubMed ID: 34978017
[TBL] [Abstract][Full Text] [Related]
11. The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors.
Hardin H; Zhang R; Helein H; Buehler D; Guo Z; Lloyd RV
Lab Invest; 2017 Oct; 97(10):1142-1151. PubMed ID: 28394318
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic and Pluripotency Aspects of Disseminated Cancer Cells During Minimal Residual Disease.
Carlini MJ; Shrivastava N; Sosa MS
Adv Exp Med Biol; 2018; 1100():1-18. PubMed ID: 30411257
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer stem cells and their potential roles in metastasis.
Li H; Tang DG
J Surg Oncol; 2011 May; 103(6):558-62. PubMed ID: 21480250
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor microenvironment on cancer stem cell fate in solid tumors.
Razi S; Haghparast A; Chodari Khameneh S; Ebrahimi Sadrabadi A; Aziziyan F; Bakhtiyari M; Nabi-Afjadi M; Tarhriz V; Jalili A; Zalpoor H
Cell Commun Signal; 2023 Jun; 21(1):143. PubMed ID: 37328876
[TBL] [Abstract][Full Text] [Related]
15. Oral Cancer Stem Cells Microenvironment.
Naik PP; Panda PK; Bhutia SK
Adv Exp Med Biol; 2017; 1041():207-233. PubMed ID: 29204835
[TBL] [Abstract][Full Text] [Related]
16. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
[TBL] [Abstract][Full Text] [Related]
17. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.
Louie E; Nik S; Chen JS; Schmidt M; Song B; Pacson C; Chen XF; Park S; Ju J; Chen EI
Breast Cancer Res; 2010; 12(6):R94. PubMed ID: 21067584
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
19. Breast-cancer stem cells-beyond semantics.
Badve S; Nakshatri H
Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment.
Wang T; Narayanaswamy R; Ren H; Torchilin VP
Cancer Biol Ther; 2016 Jun; 17(6):698-707. PubMed ID: 27259361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
